News

Features in the Media

In the news |

Nonprofit Leadership In Autism Care

Chief Clinical Officer Doreen Samelson writes for Forbes about how nonprofit autism therapy providers like Catalight and Easterseals can distinguish themselves from private equity centers that are finding themselves embroiled in claims of overbilling and fraud.

In the news |

States Move to Cut ABA Therapy Payments as Medicaid Spending Spikes

As Medicaid spending on ABA therapy continues to rise, states are reevaluating reimbursement rates and care models for autism treatment. In a recent study, Catalight Chief Clinical Officer Doreen Samelson, Ed.D., found higher therapy hours are not always linked to improved outcomes, emphasizing individualized care over a one-size-fits-all approach.

In the news |

Patient Safety Predictions for 2026

Patient Safety & Healthcare asked experts for predictions on 2026 trends in patient safety and care quality. Catalight Chief Clinical Officer Doreen Samelson, Ed.D., highlights a pivotal shift in autism and I/DD care as research drives more personalized approaches aligned with individuals’ unique goals.

In the news |

What to Know About Autism in Children

In an article on the early signs of autism, U.S. News & World Report features Catalight Chief Clinical Officer Doreen Samelson, Ed.D., MSCP, who suggests treatment that prioritizes a child’s needs and empowers parents to build skills into daily routines, reducing intensive therapy hours.

In the news |

The Future Of Autism: From Barriers To Breakthroughs

As autism prevalence continues to rise, builders are thinking more about designing spaces that are more welcoming to individuals with developmental disabilities. Catalight Chief Clinical Officer Doreen Samelson, Ed.D., tells Forbes that designers should consult with autistic advocates and families early to help further support inclusion.

Sign up for the Catalyst monthly newsletter
to find out what's new at Catalight.